Gilead Sciences, Inc.
Gilead Sciences, Inc. (NASDAQ: GILD) is trading at $150.93, about ₹14,471 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, up 0.83% today. Indian residents can buy Gilead Sciences from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$148.02
Today's high
$151.00
52 week low
$108.46
52 week high
$157.29
GILD opened at $150.18, closed previously at $149.69, and has traded between $108.46 and $157.29 over the past 52 weeks.
About
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
Key statistics
Avg. volume
7.10M
Market cap
$187.15B
P/E Ratio
-58.05
Price-to-sales ratio
6.14
Enterprise value
$210.21B
Free cash flow yield
7.05%
Debt-to-equity ratio
2.22
Return on equity
-16.28%
ROIC
-3.66%
Beta
0.35
Dividend yield
2.15%
Last dividend
$3.25
Financial overview
Revenue
$29.44B
Earnings per share
$6.84
Free cash flow
$9.46B
Net profit margin
-10.64%
Gross margin
79.59%
EBITDA
$13.58B
Revenue growth
2.39%
Similar securities
This is not an investment recommendation
How to buy Gilead Sciences from India
Indian residents can buy Gilead Sciences shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Gilead Sciences and place an order
Find Gilead Sciences by name or by its ticker, GILD, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Gilead Sciences trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Gilead Sciences position in USD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Gilead Sciences from India
Trading and taxes when buying Gilead Sciences from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. The US withholds tax on dividends paid to Indian residents at the treaty rate; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit in India. Gilead Sciences’ current yield is 2.15%.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Gilead Sciences stock?
Yes. Gilead Sciences (GILD) has been listed on NASDAQ since 1992, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Gilead Sciences share cost in rupees?
One Gilead Sciences share is $150.93 — about ₹14,471 at a USD/INR rate of 95.88 on 26 Sep 2026. Both the Gilead Sciences price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Gilead Sciences from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy Gilead Sciences with less than the price of one share?
Yes. A whole Gilead Sciences share is $150.93, but there is no minimum trade size: you enter a rupee or dollar amount and receive the matching fraction.
How are gains on Gilead Sciences shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Gilead Sciences price. Paasa issues a capital-gains statement for your return.
Does Gilead Sciences pay a dividend, and how is it taxed in India?
Yes. Gilead Sciences pays a dividend and the current yield is 2.15%; the last declared dividend was $3.25 per share, about ₹311.61. Dividends are taxed at your slab rate in India. The US withholds tax on dividends paid to Indian residents at the treaty rate; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Gilead Sciences from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Gilead Sciences shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Gilead Sciences shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Gilead Sciences holding, its cost and its closing value.
How do I sell Gilead Sciences and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.